»

Efficacy of the GelStix nucleus Augmentation – Study Protocol published, 2022

»

Global Launch Award, 2021

»

Wave Academy Webinars, 2020

»

Stimwave Surf Study, 2019

»

Wireless PNS for CRPS, Case report, 2018

»

Stimwave Neuromodulation Case Report, 2018

»

Multi-Center Efficacy Study of the GelStix™, 2016

»

»

Launch of the SphenoCath®, 2015

»

First patients treated with Epiduroscopy, 2015

»

First cadaver workshop on Epiduroscopy, 2014

Global Launch Award, 2021

Parimed team is constantly contributing to growing success of Stimwave and is awarded as the international agent of the year 2020.

»

Efficacy of the GelStix nucleus Augmentation – Study Protocol published, 2022

»

Global Launch Award, 2021

»

Wave Academy Webinars, 2020

»

Stimwave Surf Study, 2019

»

Wireless PNS for CRPS, Case report, 2018

»

Stimwave Neuromodulation Case Report, 2018

»

Multi-Center Efficacy Study of the GelStix™, 2016

»

»

Launch of the SphenoCath®, 2015

»

First patients treated with Epiduroscopy, 2015

»

First cadaver workshop on Epiduroscopy, 2014

Parimed GmbH

Data protection

Pain Management

Parkinson’s Disease Monitoring

Radiofrequency Therapy

Autologous Cytokine Therapy
Epidural Adhesiolysis

Neuromodulation
Disc - Nucleus Augmentation

Headache Treatment – SPG Block

Products

Boston Scientific RF Equipment

Epimed Epidural Catheters

Freedom Wireless Neuromodulation

GelStix Hydrogel Implant

SphenoCath Intranasal Applicator

Contact

Parimed GmbH
Unter Sagi 6
CH-6362 Stansstad

Tel.	+41 41 312 11 11
Fax	+41 41 312 11 13